Remove Health IT Remove healthcare technology Remove Leadership Remove Pharmaceuticals
article thumbnail

Abu Dhabi Global Healthcare Week: What are the key talking points likely to be?

Lloyd Price

In addition to these core areas, there will likely be discussions on specific sectors within healthcare, such as pharmaceuticals, medical management, and healthcare delivery models. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing. Subscribe Today!

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Ozempic, WeGovy, Trulicity: How GLP-1s influence Pharma and HealthTech shares

Lloyd Price

Corporate Development for Healthcare Technology companies in EMEA Healthcare Technology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions. Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors.

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations. Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making.

article thumbnail

What could Sam Altman joining Microsoft mean for Healthcare and HealthTech?

Lloyd Price

AI Business Development and Partnerships: Altman's experience in building successful businesses will be invaluable in translating AI technologies into viable healthcare solutions. AI Advocacy and Public Engagement: Altman is a strong advocate for the use of AI to address global challenges, including healthcare. Subscribe Today!

article thumbnail

Machine Learning and Computational Algorithms are revolutionising Diagnostics and attracting significant HealthTech M&A interest

Lloyd Price

Mergers, Acquisitions, Growth and Strategy for Healthcare Technology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis.

article thumbnail

HealthTech Mega Deals 2024: Big Tech's Potential Big Healthcare Acquisitions

Lloyd Price

Apple acquiring Johnson & Johnson's healthcare business. This deal would give Apple a major presence in the pharmaceutical and consumer healthcare markets. Johnson & Johnson's healthcare business includes a wide range of products, including over-the-counter medicines, prescription drugs, and medical devices.